EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis

David Koeckerling iD, Rohin K Reddy, Christian Eichhorn, Volker Braun, Yousif Ahmad, James P Howard, Fabian Aus dem Siepen, Benjamin Meder iD, Norbert Frey, Derliz Mereles

European Heart Journal Open · 04.07.2025 · 5 (4)

DOI: 10.1093/ehjopen/oeaf078 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Heart Journal Open, online erschienen am 22.08.2025. Verfasst von David Koeckerling und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology and Pulmonology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nuffield Department of Population Health, University of Oxford, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The role of echocardiography in amyloidosis prognostication remains undefined in international guidelines. This meta-analysis aims to evaluate associations between echocardiography-derived measurements and clinical outcomes in light chain (AL) and transthyretin (ATTR) amyloidosis. Methods and results MEDLINE, Embase, Cochrane Library, and Google Scholar were systematically searched through July 2024 for studies reporting associations between echocardiographic variables [left ventricular global longitudinal strain (LV-GLS), LV ejection fraction (LVEF), tricuspid annular plane systolic excursion (TAPSE), interventricular septum diameter (IVSd), LV mass index (LVMi) and E/e′ ratios] and adverse events in AL or ATTR amyloidosis. Prespecified demographic items and clinical outcomes were extracted by two blinded, independent reviewers. The prespecified primary outcome was all-cause mortality. Random-effect models were applied to pool hazard ratios (HR). 94 studies comprising 16158 patients (n = 4788 AL, n = 8241 ATTR, n = 3129 mixed aetiologies) were included. Median follow-up was 22.3 (IQR, 16.9–31.4) months. Higher all-cause mortality risk (HR, 1.10: 95%CI, 1.08–1.12; P < 0.001) was observed per 1% LV-GLS decrement, consistent across AL and ATTR subgroups. Lower all-cause mortality risk was seen with increasing LVEF (per 1%) and TAPSE (per 1 mm) in the overall population (HRLVEF, 0.98; 95%CI, 0.98–0.98; P < 0.001; and HRTAPSE, 0.94; 95%CI, 0.93–0.95; P < 0.001) and in AL and ATTR subgroups. Higher E/e′ ratios (per 1 unit) were associated with all-cause mortality (HR, 1.02; 95%CI, 1.02–1.03; P < 0.001), consistent across AL and ATTR subtypes. No reliable associations between structural parameters (IVSd, LVMi) and clinical outcomes were found.

Conclusion

Echocardiographic measures of biventricular deformation, systolic and diastolic function, were consistently associated with mortality in amyloidosis, while structural parameters were not. Echocardiography may have an important role in the initial risk stratification of cardiac amyloidosis.

Schlagwörter

Stichwörter der Autor:innen

AmyloidosisCardiomyopathyEchocardiographyLight chainTransthyretin

Autor:innen und Institutionen

  • Department of Cardiology, Angiology and Pulmonology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
  • National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW36LY, UK.
  • Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford OX37LF, UK.
  • Harvard T.H. Chan School of Public Health, Huntington Avenue, Boston, MA 02115, USA.
  • Medical Faculty Mannheim, University of Heidelberg, Ludolf-Krehl-Strasse, 68167 Mannheim, Germany.
  • Division of Cardiology, University of California, Parnassus Avenue, San Francisco, CA 94143, USA.

ORCID-Profile: David Koeckerling, Benjamin Meder

Förderung

  • Nuffield Department of Population Health
  • University of Oxford
  • British Heart Foundation

Zitieren

APA

Koeckerling, D., Reddy, R. K., Eichhorn, C., Braun, V., Ahmad, Y., Howard, J. P., Aus dem Siepen, F., Meder, B., Frey, N., & Mereles, D. (2025). Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis. European Heart Journal Open, 5(4). https://doi.org/10.1093/ehjopen/oeaf078

Vancouver

Koeckerling D, Reddy RK, Eichhorn C, Braun V, Ahmad Y, Howard JP, et al. Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis. European Heart Journal Open. 2025;5(4). doi:10.1093/ehjopen/oeaf078

BibTeX
@article{Koeckerling2025,
  author = {Koeckerling, David and Reddy, Rohin K and Eichhorn, Christian and Braun, Volker and Ahmad, Yousif and Howard, James P and Aus dem Siepen, Fabian and Meder, Benjamin and Frey, Norbert and Mereles, Derliz},
  title = {Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis},
  journal = {European Heart Journal Open},
  year = {2025},
  volume = {5},
  number = {4},
  doi = {10.1093/ehjopen/oeaf078}
}
Kostenlos starten →